Where do non-invasive colorectal cancer tools ‘FIT’ alongside colonoscopy in the surveillance of high-risk patients? (Gastro Journal)

A recent study suggests that combining fecal immunochemical testing (FIT) with colonoscopy could improve colorectal cancer surveillance for individuals with a family history of the disease. The optimal strategy involves 10-yearly colonoscopy with 2-yearly FIT screenings, providing a balance of cost-effectiveness and clinical outcomes. The study highlights the growing interest in less-invasive screening options and emphasizes the importance of maintaining quality assurance in both colonoscopy and FIT procedures. While FIT alone has limitations, the combined approach could potentially offer better cancer prevention and detection rates.